Akèy › Twoub depresif rezistan a tretman › Kalifòni
Etid klinik pou Twoub depresif rezistan a tretman nan Kalifòni
12 etid pou Twoub depresif rezistan a tretman ap chèche patisipan nan sit nan Kalifòni.
Vil nan Kalifòni
Tèks ofisyèl etid la (Anglè)
A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression
- Anderson Clinical Research, Redlands
- Artemis Institute for Clinical Research, San Diego
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07716098Spaced Transcranial Direct Current Stimulation for Treatment-Resistant Depression: A Home-Based Feasibility and Safety Study
- UCSD Interventional Psychiatry, San Diego
Ap rekrite
Laj 18 a 85 · Tout sèks · Mizajou Sep 15, 2026 · NCT07217223ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
- Inland Psychiatric Medical Group, Chino
- Behavioral Research Specialists, LLC, Glendale
- Kadima Neuropsychiatry Institute, La Jolla
- ak 1 plis
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 14, 2026 · NCT07284667Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- USC University Hospital, Los Angeles
- UCLA Department of Psychiatry, Los Angeles
- University of California at Davis, Sacramento
Ap rekrite
Laj 22 a 70 · Tout sèks · Mizajou Aug 28, 2026 · NCT06423430A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
- ATP Clinical Research, Inc., Costa Mesa
- Kaizen Brain Center, La Jolla
- Keck Hospital of USC, Los Angeles
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 15, 2026 · NCT03887715A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- CenExel, Garden Grove
- Behavioral Research Specialists, LLC, Glendale
- Kadima Neuropsychiatry Institute, La Jolla
- ak 2 plis
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou May 11, 2026 · NCT06524830Mindfulness Engaged Neurostimulation for Depression (MEND II)
- UC San Diego Health Psychiatry, San Diego
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou May 6, 2026 · NCT07512284Maintenance rTMS for Depression (Maitr-De)
- University of California, San Diego, San Diego
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Apr 29, 2026 · NCT06938841ALTO-207 in Adults With Treatment-resistant Depression (TRD)
- Site 7153, Chino
- Site 7156, Oakland
- Site 7082, Oceanside
- ak 4 plis
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Apr 28, 2026 · NCT07553637ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1
- Salma Health, La Jolla
- Salma Health, Laguna Hills
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Apr 14, 2026 · NCT07528014Biomarker-guided rTMS for Treatment Resistant Depression
- Stanford University, Stanford
Ap rekriteFaz 3
Laj 22 a 65 · Tout sèks · Mizajou Feb 25, 2026 · NCT04041479Cortical Inhibition as a Biomarker of Response in a Comparison of Bilateral Versus Unilateral Accelerated Theta Burst Stimulation for Suicidal Ideation in Treatment-Resistant Depression -COMBAT-SI
- UCSD Interventional Psychiatry, San Diego
Ap rekrite
Laj 18 a 70 · Tout sèks · Mizajou Nov 5, 2025 · NCT05377177Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.